Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...
Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...
Danish pharmaceutical company, Novo Nordisk, is set to introduce its diabetes drug, Ozempic, in India this December ...
A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...
A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger ...
India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...
For countless fat jab users, a swollen tummy, waves of nausea and embarrassing gas have become part and parcel of the ...
News9Live on MSN
Novo Nordisk’s Ozempic eyes India launch this December: Sources
Danish pharmaceutical giant has been steadily expanding its presence in India, and the arrival of Ozempic marks a significant move in a country grappling with fast-rising rates of type 2 diabetes and ...
Norwegian patients and researchers at Akershus University Hospital and Oslo University Hospital have taken part in two large ...
Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division recommended Willow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback